<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000599960">
  <TermName>1-methyl-d-tryptophan</TermName>
  <TermPronunciation>(1-MEH-thul-d-TRIP-toh-fan)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A substance being studied in the treatment of melanoma and many other types of cancer. 1-methyl-d-tryptophan blocks the breakdown of the amino acid tryptophan, which is needed for T cells (a type of immune system cell) to kill tumor cells. Giving 1-methyl-d-tryptophan to patients who have received chemotherapy for cancer may help kill more tumor cells. It is a type of enzyme inhibitor and immunosuppressant. Also called D-1MT.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000721195" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;1-methyl-d-tryptophan&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000721196" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;1-metilo-d-triptófano&quot;" language="es" id="_4"/>
  <SpanishTermName>1-metilo-d-triptófano</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia en estudio para el tratamiento del melanoma y muchos otros tipos de cáncer. El 1-metilo-d-triptófano impide el deterioro del aminoácido triptófano que las células T (un tipo de célula del sistema inmunitario) necesitan para destruir las células tumorales. La administración de 1-metilo-d-triptófano a los pacientes que recibieron quimioterapia para el cáncer puede ayudar a destruir más células tumorales. Es un tipo de inhibidor enzimático y de inmunodepresor. También se llama D-1MT.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2008-07-14</DateFirstPublished>
</GlossaryTerm>
